Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Entities / Dolutegravir
Other

Dolutegravir

Tracked across 1 events · 56 articles · First seen Jun 09, 2026 · Last active Jun 10, 2026

Sentiment
-20
Attention
6
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
6 -20
Business
GSK acquires Nuvalent for $10.6B
GSK plc>>> has agreed to acquire GSK plc>>>, a US cancer drug firm, for $10.6 billion (£8 billion) in an all-cash deal. This acquisition, GSK plc>>>'s largest in over a decade, aims to significantly expand…
Impact: The impending patent expiration of Dolutegravir>>>, an HIV drug, is a key driver for GSK plc>>>'s strategy to acquire new revenue streams through deals like the GSK plc>>> acquisition.
Jun 09, 2026 · 56 articles
NEWSDESK
Track Dolutegravir live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.